The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Intravenous Immunoglobulin(IVIg) Therapy Market Research Report 2025

Global Intravenous Immunoglobulin(IVIg) Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1729166

No of Pages : 115

Ask Your Query

Synopsis
Highlights
The global Intravenous Immunoglobulin(IVIg) Therapy market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Intravenous Immunoglobulin(IVIg) Therapy include TEIJIN LIMITED, Grifols, Biotest, Kamada, Takeda, Octapharma, Kedrion, LFB Group and Baxter, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Intravenous Immunoglobulin(IVIg) Therapy in Immunodeficiency is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, 1g/20ml, which accounted for % of the global market of Intravenous Immunoglobulin(IVIg) Therapy in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin(IVIg) Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin(IVIg) Therapy.
The Intravenous Immunoglobulin(IVIg) Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Intravenous Immunoglobulin(IVIg) Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Immunoglobulin(IVIg) Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • TEIJIN LIMITED
  • Grifols
  • Biotest
  • Kamada
  • Takeda
  • Octapharma
  • Kedrion
  • LFB Group
  • Baxter
  • Nanyue Biopharming
  • Boya-Bio
  • CSL Plasma
  • CNBG
  • Beijing Tiantan Biological Products
  • Hualan Bio
  • Guangdong Shuagnlin Bio-pharmacy
  • Weiguang Biological
  • Sinopharm
  • Shanghai RAAS
  • Taibang Biologic Group

Product Type Insights
Global markets are presented by Intravenous Immunoglobulin(IVIg) Therapy type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Intravenous Immunoglobulin(IVIg) Therapy are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Intravenous Immunoglobulin(IVIg) Therapy segment by Type

  • 1g/20ml
  • 1.25g/25ml
  • 2.5g/50ml
  • 5g/100ml
  • 10g/200ml
  • Others

Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Intravenous Immunoglobulin(IVIg) Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Intravenous Immunoglobulin(IVIg) Therapy market.
Intravenous Immunoglobulin(IVIg) Therapy segment by Application

  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection
  • Others

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Intravenous Immunoglobulin(IVIg) Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin(IVIg) Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin(IVIg) Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Intravenous Immunoglobulin(IVIg) Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin(IVIg) Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Immunoglobulin(IVIg) Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Immunoglobulin(IVIg) Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

Index

1 Intravenous Immunoglobulin(IVIg) Therapy Market Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulin(IVIg) Therapy
1.2 Intravenous Immunoglobulin(IVIg) Therapy Segment by Type
1.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.2.7 Others
1.3 Intravenous Immunoglobulin(IVIg) Therapy Segment by Application
1.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Comparison by Application: (2022-2028)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.3.5 Others
1.4 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2028
1.4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2028
1.4.3 Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region: 2017 Versus 2021 Versus 2028
2 Intravenous Immunoglobulin(IVIg) Therapy Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Manufacturers (2017-2022)
2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Intravenous Immunoglobulin(IVIg) Therapy Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Sites, Area Served, Product Type
2.5 Intravenous Immunoglobulin(IVIg) Therapy Market Competitive Situation and Trends
2.5.1 Intravenous Immunoglobulin(IVIg) Therapy Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Intravenous Immunoglobulin(IVIg) Therapy Players Market Share by Revenue
2.5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Immunoglobulin(IVIg) Therapy Retrospective Market Scenario by Region
3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.3.1 North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
3.3.2 North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.4.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
3.4.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Region
3.5.1 Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Region
3.5.2 Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.6.1 Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
3.6.2 Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
3.7.2 Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Intravenous Immunoglobulin(IVIg) Therapy Historic Market Analysis by Type
4.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
4.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2017-2022)
4.3 Global Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2017-2022)
5 Global Intravenous Immunoglobulin(IVIg) Therapy Historic Market Analysis by Application
5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2017-2022)
5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2017-2022)
6 Key Companies Profiled
6.1 TEIJIN LIMITED
6.1.1 TEIJIN LIMITED Corporation Information
6.1.2 TEIJIN LIMITED Description and Business Overview
6.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.1.4 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.1.5 TEIJIN LIMITED Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Biotest
6.3.1 Biotest Corporation Information
6.3.2 Biotest Description and Business Overview
6.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.3.5 Biotest Recent Developments/Updates
6.4 Kamada
6.4.1 Kamada Corporation Information
6.4.2 Kamada Description and Business Overview
6.4.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.4.5 Kamada Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 Octapharma
6.6.1 Octapharma Corporation Information
6.6.2 Octapharma Description and Business Overview
6.6.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.6.5 Octapharma Recent Developments/Updates
6.7 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.7.5 Kedrion Recent Developments/Updates
6.8 LFB Group
6.8.1 LFB Group Corporation Information
6.8.2 LFB Group Description and Business Overview
6.8.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.8.4 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.8.5 LFB Group Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 Nanyue Biopharming
6.10.1 Nanyue Biopharming Corporation Information
6.10.2 Nanyue Biopharming Description and Business Overview
6.10.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.10.5 Nanyue Biopharming Recent Developments/Updates
6.11 Boya-Bio
6.11.1 Boya-Bio Corporation Information
6.11.2 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.11.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.11.5 Boya-Bio Recent Developments/Updates
6.12 CSL Plasma
6.12.1 CSL Plasma Corporation Information
6.12.2 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.12.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.12.4 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.12.5 CSL Plasma Recent Developments/Updates
6.13 CNBG
6.13.1 CNBG Corporation Information
6.13.2 CNBG Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.13.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.13.4 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.13.5 CNBG Recent Developments/Updates
6.14 Beijing Tiantan Biological Products
6.14.1 Beijing Tiantan Biological Products Corporation Information
6.14.2 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.14.5 Beijing Tiantan Biological Products Recent Developments/Updates
6.15 Hualan Bio
6.15.1 Hualan Bio Corporation Information
6.15.2 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.15.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.15.5 Hualan Bio Recent Developments/Updates
6.16 Guangdong Shuagnlin Bio-pharmacy
6.16.1 Guangdong Shuagnlin Bio-pharmacy Corporation Information
6.16.2 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.16.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.16.5 Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
6.17 Weiguang Biological
6.17.1 Weiguang Biological Corporation Information
6.17.2 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.17.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.17.5 Weiguang Biological Recent Developments/Updates
6.18 Sinopharm
6.18.1 Sinopharm Corporation Information
6.18.2 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.18.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.18.5 Sinopharm Recent Developments/Updates
6.19 Shanghai RAAS
6.19.1 Shanghai RAAS Corporation Information
6.19.2 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.19.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.19.5 Shanghai RAAS Recent Developments/Updates
6.20 Taibang Biologic Group
6.20.1 Taibang Biologic Group Corporation Information
6.20.2 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Description and Business Overview
6.20.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Portfolio
6.20.5 Taibang Biologic Group Recent Developments/Updates
7 Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Cost Analysis
7.1 Intravenous Immunoglobulin(IVIg) Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
7.4 Intravenous Immunoglobulin(IVIg) Therapy Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors List
8.3 Intravenous Immunoglobulin(IVIg) Therapy Customers
9 Intravenous Immunoglobulin(IVIg) Therapy Market Dynamics
9.1 Intravenous Immunoglobulin(IVIg) Therapy Industry Trends
9.2 Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
9.3 Intravenous Immunoglobulin(IVIg) Therapy Market Challenges
9.4 Intravenous Immunoglobulin(IVIg) Therapy Market Restraints
10 Global Market Forecast
10.1 Intravenous Immunoglobulin(IVIg) Therapy Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intravenous Immunoglobulin(IVIg) Therapy by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Intravenous Immunoglobulin(IVIg) Therapy by Type (2023-2028)
10.2 Intravenous Immunoglobulin(IVIg) Therapy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intravenous Immunoglobulin(IVIg) Therapy by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Intravenous Immunoglobulin(IVIg) Therapy by Application (2023-2028)
10.3 Intravenous Immunoglobulin(IVIg) Therapy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravenous Immunoglobulin(IVIg) Therapy by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Intravenous Immunoglobulin(IVIg) Therapy by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Intravenous Immunoglobulin(IVIg) Therapy Market Competitive Situation by Manufacturers in 2021
Table 5. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Intravenous Immunoglobulin(IVIg) Therapy Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Sites and Area Served
Table 11. Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intravenous Immunoglobulin(IVIg) Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin(IVIg) Therapy as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2017-2022) & (K Units)
Table 16. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2017-2022)
Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2017-2022)
Table 19. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 20. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 21. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 23. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 24. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 25. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2017-2022)
Table 31. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 33. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 39. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 40. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 41. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Type (2017-2022)
Table 43. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Application (2017-2022)
Table 45. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 46. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Application (2017-2022)
Table 48. Global Intravenous Immunoglobulin(IVIg) Therapy Price by Application (2017-2022) & (US$/Unit)
Table 49. TEIJIN LIMITED Corporation Information
Table 50. TEIJIN LIMITED Description and Business Overview
Table 51. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product
Table 53. TEIJIN LIMITED Recent Developments/Updates
Table 54. Grifols Corporation Information
Table 55. Grifols Description and Business Overview
Table 56. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product
Table 58. Grifols Recent Developments/Updates
Table 59. Biotest Corporation Information
Table 60. Biotest Description and Business Overview
Table 61. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product
Table 63. Biotest Recent Developments/Updates
Table 64. Kamada Corporation Information
Table 65. Kamada Description and Business Overview
Table 66. Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product
Table 68. Kamada Recent Developments/Updates
Table 69. Takeda Corporation Information
Table 70. Takeda Description and Business Overview
Table 71. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product
Table 73. Takeda Recent Developments/Updates
Table 74. Octapharma Corporation Information
Table 75. Octapharma Description and Business Overview
Table 76. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product
Table 78. Octapharma Recent Developments/Updates
Table 79. Kedrion Corporation Information
Table 80. Kedrion Description and Business Overview
Table 81. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product
Table 83. Kedrion Recent Developments/Updates
Table 84. LFB Group Corporation Information
Table 85. LFB Group Description and Business Overview
Table 86. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product
Table 88. LFB Group Recent Developments/Updates
Table 89. Baxter Corporation Information
Table 90. Baxter Description and Business Overview
Table 91. Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product
Table 93. Baxter Recent Developments/Updates
Table 94. Nanyue Biopharming Corporation Information
Table 95. Nanyue Biopharming Description and Business Overview
Table 96. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product
Table 98. Nanyue Biopharming Recent Developments/Updates
Table 99. Boya-Bio Corporation Information
Table 100. Boya-Bio Description and Business Overview
Table 101. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product
Table 103. Boya-Bio Recent Developments/Updates
Table 104. CSL Plasma Corporation Information
Table 105. CSL Plasma Description and Business Overview
Table 106. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product
Table 108. CSL Plasma Recent Developments/Updates
Table 109. CNBG Corporation Information
Table 110. CNBG Description and Business Overview
Table 111. CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product
Table 113. CNBG Recent Developments/Updates
Table 114. Beijing Tiantan Biological Products Corporation Information
Table 115. Beijing Tiantan Biological Products Description and Business Overview
Table 116. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product
Table 118. Beijing Tiantan Biological Products Recent Developments/Updates
Table 119. Hualan Bio Corporation Information
Table 120. Hualan Bio Description and Business Overview
Table 121. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product
Table 123. Hualan Bio Recent Developments/Updates
Table 124. Guangdong Shuagnlin Bio-pharmacy Corporation Information
Table 125. Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
Table 126. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product
Table 128. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
Table 129. Weiguang Biological Corporation Information
Table 130. Weiguang Biological Description and Business Overview
Table 131. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product
Table 133. Weiguang Biological Recent Developments/Updates
Table 134. Sinopharm Corporation Information
Table 135. Sinopharm Description and Business Overview
Table 136. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product
Table 138. Sinopharm Recent Developments/Updates
Table 139. Shanghai RAAS Corporation Information
Table 140. Shanghai RAAS Description and Business Overview
Table 141. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product
Table 143. Shanghai RAAS Recent Developments/Updates
Table 144. Taibang Biologic Group Corporation Information
Table 145. Taibang Biologic Group Description and Business Overview
Table 146. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product
Table 148. Taibang Biologic Group Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Intravenous Immunoglobulin(IVIg) Therapy Distributors List
Table 152. Intravenous Immunoglobulin(IVIg) Therapy Customers List
Table 153. Intravenous Immunoglobulin(IVIg) Therapy Market Trends
Table 154. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
Table 155. Intravenous Immunoglobulin(IVIg) Therapy Market Challenges
Table 156. Intravenous Immunoglobulin(IVIg) Therapy Market Restraints
Table 157. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Type (2023-2028) & (K Units)
Table 158. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Application (2023-2028) & (K Units)
Table 162. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2023-2028) & (K Units)
Table 166. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin(IVIg) Therapy
Figure 2. Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Type in 2021 & 2028
Figure 3. 1g/20ml Product Picture
Figure 4. 1.25g/25ml Product Picture
Figure 5. 2.5g/50ml Product Picture
Figure 6. 5g/100ml Product Picture
Figure 7. 10g/200ml Product Picture
Figure 8. Others Product Picture
Figure 9. Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Application in 2021 & 2028
Figure 10. Immunodeficiency
Figure 11. Autoimmune Disease
Figure 12. Acute Infection
Figure 13. Others
Figure 14. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size (2017-2028) & (US$ Million)
Figure 16. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (2017-2028) & (K Units)
Figure 17. Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Manufacturers in 2021
Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Manufacturers in 2021
Figure 19. The Global 5 and 10 Largest Intravenous Immunoglobulin(IVIg) Therapy Players: Market Share by Revenue in 2021
Figure 20. Intravenous Immunoglobulin(IVIg) Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2017-2022)
Figure 22. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region in 2021
Figure 23. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2017-2022)
Figure 24. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region in 2021
Figure 25. United States Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Canada Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Germany Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. France Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. U.K. Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Italy Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Russia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Japan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. South Korea Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. India Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Australia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. China Taiwan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Indonesia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Thailand Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Malaysia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Colombia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Turkey Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Saudi Arabia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. UAE Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Sales Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Type (2017-2022)
Figure 49. Manufacturing Cost Structure of Intravenous Immunoglobulin(IVIg) Therapy
Figure 50. Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
Figure 51. Intravenous Immunoglobulin(IVIg) Therapy Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock